Novel Coronavirus (COVID-19)

UW-TASP is committed to supporting our members and the wider community in managing and preventing the spread of COVID-19.

In late February, Washington became an epicenter of the novel coronavirus in the US, (COVID-19). This virus causes respiratory tract infections similar to the flu. In the upcoming weeks, we anticipate increased spread throughout our communities including across state lines. While the majority of respiratory infections due to this virus are mild and can be managed at home, patients older than 65 years and particularly those with comorbid health conditions are at risk of severe disease and complications. Healthcare workers are at particular risk of transmission due to their presence on the frontline. To this end, UW-TASP will support you with our interpretation and implementation of public health guidance.

Click here for COVID-19 resources

The Challenge of Antibiotic Resistance is Here

Rising antibiotic resistance is one of the greatest health threats of our time and requires that every healthcare institution develop effective interventions that promote the judicious use of antimicrobials. Small, rural, and critical access hospitals are key players in this fight, yet often lack the time and resources to independently create robust antimicrobial stewardship programs.

The UW-TASP community is made up of physicians, nurses, pharmacists, infection preventionists, microbiologists and other allied healthcare professionals all with the common goal of improving patient care. This includes appropriate and thoughtful usage of antimicrobials as well optimizing management of infectious diseases. Faculty include University of Washington physicians, pharmacists, microbiologists, and nurses who are clinicians, researchers, and teachers. We share evidenced-based data to optimize diagnostics, treatment, patient care, and program management in healthcare environments. By combining the resources available in our urban academic setting with the expertise of rural health providers, antimicrobial stewardship program implementation has been accelerated throughout the region with far reaching benefits to our community. 

UW TASP combines:

  • Weekly tele-conferences with clinical didactics case discussions

  • Tele-mentoring with UW ID physicians, ID pharmacists, nurses, and clinical microbiologists

  • AMS site assessment and annual site visits

  • Remote grand rounds

  • Annual conference

For more information, or to join our program, contact: uwtasp@uw.edu

John Lynch, MD, MPH
 Principal Investigator and Medical Director
 Chloe Bryson-Cahn, MD
 Associate Medical Director 
 Zahra Kassamali, PharmD
 Associate Medical Director 
 Jeannie Chan, PharmD 
 TASP Faculty
 Rupali Jain, PharmD
 TASP Faculty
 Paul Pottinger, MD
 TASP Faculty
 Natalia Martinez-Paz, MPA, MA
 TASP Program Manager